Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells

Am J Physiol Cell Physiol. 2009 Feb;296(2):C285-95. doi: 10.1152/ajpcell.00418.2008. Epub 2008 Dec 3.

Abstract

The vectorial transport of ions and water across epithelial cells depends to a large extent on the coordination of the apical and basolateral ion fluxes with energy supply. In this work we provide the first evidence for a regulation by the 5'-AMP-activated protein kinase (AMPK) of the calcium-activated potassium channel KCa3.1 expressed at the basolateral membrane of a large variety of epithelial cells. Inside-out patch-clamp experiments performed on human embryonic kidney (HEK) cells stably transfected with KCa3.1 first revealed a decrease in KCa3.1 activity following the internal addition of AMP at a fixed ATP concentration. This effect was dose dependent with half inhibition at 140 muM AMP in 1 mM ATP. Evidence for an interaction between the COOH-terminal region of KCa3.1 and the gamma1-subunit of AMPK was next obtained by two-hybrid screening and pull-down experiments. Our two-hybrid analysis confirmed in addition that the amino acids extending from Asp(380) to Ala(400) in COOH-terminal were essential for the interaction AMPK-gamma1/KCa3.1. Inside-out experiments on cells coexpressing KCa3.1 with the dominant negative AMPK-gamma1-R299G mutant showed a reduced sensitivity of KCa3.1 to AMP, arguing for a functional link between KCa3.1 and the gamma1-subunit of AMPK. More importantly, coimmunoprecipitation experiments carried out on bronchial epithelial NuLi cells provided direct evidence for the formation of a KCa3.1/AMPK-gamma1 complex at endogenous AMPK and KCa3.1 expression levels. Finally, treating NuLi monolayers with the membrane permeant AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) caused a significant decrease of the KCa3.1-mediated short-circuit currents, an effect reversible by coincubation with the AMPK inhibitor Compound C. These observations argue for a regulation of KCa3.1 by AMPK in a functional epithelium through protein/protein interactions involving the gamma1-subunit of AMPK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Adenosine Monophosphate / metabolism
  • Adenosine Triphosphate / metabolism
  • Aminoimidazole Carboxamide / analogs & derivatives
  • Aminoimidazole Carboxamide / pharmacology
  • Cell Polarity
  • Cells, Cultured
  • Enzyme Activation
  • Enzyme Activators / pharmacology
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology*
  • Humans
  • Immunoprecipitation
  • Intermediate-Conductance Calcium-Activated Potassium Channels / antagonists & inhibitors
  • Intermediate-Conductance Calcium-Activated Potassium Channels / genetics
  • Intermediate-Conductance Calcium-Activated Potassium Channels / metabolism*
  • Ion Channel Gating* / drug effects
  • Ion Transport
  • Membrane Potentials
  • Mutation
  • Patch-Clamp Techniques
  • Protein Binding
  • Recombinant Proteins / metabolism
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / enzymology*
  • Ribonucleotides / pharmacology
  • Transfection
  • Two-Hybrid System Techniques

Substances

  • Enzyme Activators
  • Intermediate-Conductance Calcium-Activated Potassium Channels
  • KCNN4 protein, human
  • Recombinant Proteins
  • Ribonucleotides
  • Aminoimidazole Carboxamide
  • Adenosine Monophosphate
  • Adenosine Triphosphate
  • PRKAG1 protein, human
  • AMP-Activated Protein Kinases
  • AICA ribonucleotide